Facebook, Twitter poised to beat suit over Covid vaccine misinformation

The proposed class-action lawsuit tried to get around law by claiming that Meta's Facebook and Twitter breached their contracts with users

vaccine, covid vaccine, covid-19 vaccine
Photo: Bloomberg
Robert Burnson | Bloomberg
1 min read Last Updated : Dec 08 2022 | 8:05 AM IST
Meta Platforms Inc. and Twitter Inc. can’t be held liable for misinformation posted by users about Covid-19 vaccines even if the posts violate company policies, a judge said.
 
In a tentative ruling Wednesday, a state judge in San Jose, California, based his ruling on the US Communications Decency Act. Section 230 of the law gives broad immunity to interactive computer services for content posted by third parties.

The proposed class-action lawsuit tried to get around law by claiming that Meta’s Facebook and Twitter breached their contracts with users by failing to enforce company policies for preventing the spread of misinformation.

Superior Court Judge Sunil Kulkarni said that no matter how the complaint was styled, it was still trying to hold the companies liable for third-party content, which Section 230 doesn’t allow.

The case is Ackers v. Facebook Inc., 21CV387172, California Superior Court, Santa Clara County (San Jose).

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusFacebookTwitterCoronavirus Vaccine

Next Story